| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10235069 | New Biotechnology | 2013 | 25 Pages |
Abstract
⺠Proteomics methodology could expand the diagnostic tools available to clinics. ⺠Proteins as the endpoint of biological processes hold advantage over RNA approaches. ⺠Heterogeneity of tumours presents a great challenge for proteomics. ⺠Lack of standardisation presents a barrier for easy integration into clinics. ⺠High-throughput proteomics will aid the development of personalised medicine.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Nina KoÄevar, Petra Hudler, Radovan Komel,